GnT-IVA Antibodies

Santa Cruz Biotechnology delivers a wide array of GnT-IVA monoclonal antibodies for advanced research in glycosylation processes. GnT-IVA monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GnT-IVA, or N-acetylglucosaminyltransferase IV A, plays a crucial role in the modification of glycoproteins, influencing stability, function, and interactions. The enzyme is essential for the synthesis of complex N-glycans, which are vital for cell signaling, immune response, and overall cellular communication. Understanding GnT-IVA function is important for elucidating implications in various diseases, including cancer and autoimmune disorders. Research has shown that GnT-IVA expression levels can significantly impact cellular behavior and disease progression. Studying GnT-IVA activity provides insights into potential therapeutic targets for various pathological conditions. Investigating N-glycan modifications helps reveal the complex mechanisms underlying cellular processes and disease development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance our understanding of glycosylation's role in human health and disease.